Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEG33773 in painful diabetic peripheral neuropathy
2009-011254-18Phase 2Completed
- Sponsor
- Aegera Therapeutics
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing AEG33773 with Placebo (2 arms). Primary endpoint: Change in mean NPRS score from baseline to end of 4-week treatment. Started Jul 2009; status: completed.
02
Drugs
AEG33773
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2009-011254-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011254-18.